Tagged with P

Pharma Legal Handbook All legal aspects surrounding cannabinoid drugs, medicinal cannabis and opioid drugs in Colombia. Prepared in association with Cavelier Abogados, a leading law firm in Colombia, this is an extract from The Pharma Legal Handbook: Colombia, available to purchase here for GBP 119. Cannabinoid Drugs 1. Are Cannabinoid Drugs authorized in…

Pharma Legal Handbook The key facts about biosimilars and biologics in Colombia. Prepared in association with Cavelier Abogados, a leading global law firm, this is an extract from The Pharma Legal Handbook: Colombia, available to purchase here for GBP 119.   1. Are biosimilar medicines considered the same as generic medicines in your country?…

China China’s strict ‘dynamic COVID-zero’ policy, relying on lockdowns, mass-testing and border controls to stamp out COVID-19 outbreaks wherever they appear, has undoubtedly constricted the country’s economic growth and prompted uncommon displays of anti-government public dissent. Some observers are even speculating that the policy could have a greater impact on the…

India The latest news from the Indian pharma sector, including the potential for greater numbers of exports and better market access to the UK under a proposed free trade agreement, yet another scandal – this time over contaminated cough syrup in Gambia –, and why 200 million doses of Bharat Biotech’s…

Denmark Henrik Brabrand, CEO of life science-focused executive search firm Albright Partners A/S, gives his expert insight into how to stand out above the crowd and get noticed by headhunters.   So, you have decided that you may be up for a new challenge. You may not know it yet, but…

Egypt Boehringer Ingelheim’s Marianne Abou Elkheir, General Manager and Head of Human Pharma for Levant, Iraq and North-East Africa (LINEA) and Sub-Saharan Africa (SSA), walks us through her career trajectory and her experiences in leading pharma and medtech organisations. In addition, she dives into Egypt’s healthcare transformation and trends in the…

Egypt As Egypt moves towards universal healthcare coverage for its 100 million-plus population, the country has become the fastest growing pharma market in the Middle East and Africa region with a value of USD 6.3 billion. Here are some of the key trends to watch in Egypt as identified by local…

Egypt Dr Amel El Beshlawy, founder of Egyptian Thalassemia Association (ETA) and Professor of Pediatric Hematology at the Pediatric Hospital of Cairo University, is considered the Middle East’s leading authority on Thalassemia, having made an enduring contribution not only to improving the survival rate of thalassemia patients in her clinical practice,…

Americas The Head of Viatris Latin America, Patrick Doyle, spoke to PharmaBoardroom about setting up the two-year old company’s Latam affiliate during the pandemic, the decision to focus on specific therapeutic areas—cardiovascular disease, central nervous system (CNS) disorders, and pain—in LatAm and Viatris’ aim to partner with local stakeholders and go…

Pharma Legal Handbook An intro to the regulatory, pricing and reimbursement scenario for pharmaceuticals in China. Prepared in association with Fangda Partners, one of China’s most prestigious and well-regarded law firms. This is an extract from The Pharma Legal Handbook: China, which can be purchased here for GBP 119.   1. What are…

Pharma Legal Handbook The essential requirements for conducting preclinical and clinical trials in China. Prepared in association with Fangda Partners, one of China’s most prestigious and well-regarded law firms. This is an extract from The Pharma Legal Handbook: China, which can be purchased here for GBP 119.   1. Are clinical trials required to…

Pharma Legal Handbook A brief overview of the situation regarding marketing, manufacturing, packaging & labeling and advertising within Chinese pharma. Prepared in association with Fangda Partners, one of China’s most prestigious and well-regarded law firms. This is an extract from The Pharma Legal Handbook: China, which can be purchased here for GBP 119.  …